[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Vandghanooni et al., 2021 - Google Patents

Recent advances in aptamer-based nanosystems and microfluidics devices for the detection of ovarian cancer biomarkers

Vandghanooni et al., 2021

Document ID
9508976033493843860
Author
Vandghanooni S
Sanaat Z
Barar J
Adibkia K
Eskandani M
Omidi Y
Publication year
Publication venue
TrAC Trends in Analytical Chemistry

External Links

Snippet

Cost-efficient sensitive detection of solid tumor markers in patients' serums with high accuracy and specificity has been a striking challenge. The early detection of ovarian cancer (OC) can significantly increase the survival rate of patients. Additional to the aptamer (Ap) …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays

Similar Documents

Publication Publication Date Title
Vandghanooni et al. Recent advances in aptamer-based nanosystems and microfluidics devices for the detection of ovarian cancer biomarkers
Xu et al. Optical, electrochemical and electrical (nano) biosensors for detection of exosomes: A comprehensive overview
Shen et al. Current detection technologies for circulating tumor cells
Zhang et al. Nanotechnology in cancer diagnosis: progress, challenges and opportunities
Lin et al. Progress in microfluidics‐based exosome separation and detection technologies for diagnostic applications
Song et al. Fluorescent-magnetic-biotargeting multifunctional nanobioprobes for detecting and isolating multiple types of tumor cells
Bhana et al. Nanotechnology for enrichment and detection of circulating tumor cells
Wang et al. Simultaneous isolation and detection of circulating tumor cells with a microfluidic silicon-nanowire-array integrated with magnetic upconversion nanoprobes
Wen et al. Quick-response magnetic nanospheres for rapid, efficient capture and sensitive detection of circulating tumor cells
Xiang et al. Nanomaterial-based microfluidic systems for cancer biomarker detection: recent applications and future perspectives
Zhang et al. Novel nitrocellulose membrane substrate for efficient analysis of circulating tumor cells coupled with surface-enhanced Raman scattering imaging
Xie et al. A novel electrochemical microfluidic chip combined with multiple biomarkers for early diagnosis of gastric cancer
Ravalli et al. Gold and magnetic nanoparticles-based electrochemical biosensors for cancer biomarker determination
Yin et al. A multifunctional platform for the capture, release, and enumeration of circulating tumor cells based on aptamer binding, nicking endonuclease-assisted amplification, and inductively coupled plasma mass spectrometry detection
Xing et al. Analysis of extracellular vesicles as emerging theranostic nanoplatforms
Zhao et al. State-of-the-art nanotechnologies for the detection, recovery, analysis and elimination of liquid biopsy components in cancer
Gribko et al. Is small smarter? Nanomaterial-based detection and elimination of circulating tumor cells: Current knowledge and perspectives
Yu et al. Recent advances in cell membrane camouflage-based biosensing application
Austin et al. Clinical utility of non-EpCAM based circulating tumor cell assays
Solhi et al. Critical role of biosensing on the efficient monitoring of cancer proteins/biomarkers using label-free aptamer based bioassay
Kumar et al. Recent advances in nanotechnology and microfluidic-based approaches for isolation and detection of circulating tumor cells (CTCs)
PramaniK et al. Multifunctional hybrid graphene oxide for circulating tumor cell isolation and analysis
Yue et al. Micro/nanofluidic technologies for efficient isolation and detection of circulating tumor cells
Zamay et al. Aptamer-based methods for detection of circulating tumor cells and their potential for personalized diagnostics
Zhang et al. Nanomaterials in microfluidics for disease diagnosis and therapy development